Y43.8
Other primarily systemic agents, not elsewhere classified
⇄ Primary-code rule changed vs QĐ4469
Coding rules (TT06)
- ●Cannot be used as primary diagnosis
Coding guidance (WHO 2019)
Heavy-metal antagonists
Sibling codes
Y43Primarily systemic agentsY43.0Antiallergic and antiemetic drugsY43.1Antineoplastic antimetabolitesY43.2Antineoplastic natural productsY43.3Other antineoplastic drugsY43.4Immunosuppressive agentsY43.5Acidifying and alkalizing agentsY43.6Enzymes, not elsewhere classifiedY43.9Primarily systemic agent, unspecified